These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15029874)

  • 1. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy.
    Wickström K; Edelstam G; Löwbeer CH; Hansson LO; Siegbahn A
    Scand J Clin Lab Invest; 2004; 64(1):31-40. PubMed ID: 15029874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and cord blood hemostasis at delivery.
    Schneider DM; von Tempelhoff GF; Herrle B; Heilmann L
    J Perinat Med; 1997; 25(1):55-61. PubMed ID: 9085204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia.
    Deng L; Bremme K; Hansson LO; Blombäck M
    Obstet Gynecol; 1994 Dec; 84(6):941-5. PubMed ID: 7970473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
    Yang Y; Hu Y; Wu M; Xiang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):469-478. PubMed ID: 35545342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
    Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
    Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy.
    Sié P; Caron C; Azam J; Goudemand J; Grandjean H; Boneu B; Fournié A
    Br J Haematol; 2003 Jun; 121(6):897-903. PubMed ID: 12786801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery.
    Reinthaller A; Mursch-Edlmayr G; Tatra G
    Br J Obstet Gynaecol; 1990 Jun; 97(6):506-10. PubMed ID: 2198919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy.
    Sen C; Madazh R; Kavuzlu C; Ocak V; Tolun N
    J Perinat Med; 1994; 22(1):29-38. PubMed ID: 8035292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostasis in normal pregnancy.
    Stirling Y; Woolf L; North WR; Seghatchian MJ; Meade TW
    Thromb Haemost; 1984 Oct; 52(2):176-82. PubMed ID: 6084322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes.
    Uszyński M
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):127-31. PubMed ID: 9447363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet behaviour on von Willebrand Factor changes in pregnancy: Consequences of haemodilution and intrinsic changes in platelet function.
    Cowman J; Müllers S; Dunne E; Ralph A; Ricco AJ; Malone FD; Kenny D
    Sci Rep; 2017 Jul; 7(1):6354. PubMed ID: 28743915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood coagulation and fibrinolysis in the normal puerperium.
    Dahlman T; Hellgren M; Blombäck M
    Gynecol Obstet Invest; 1985; 20(1):37-44. PubMed ID: 3930349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference values for thrombotic markers in children.
    Sosothikul D; Kittikalayawong Y; Aungbamnet P; Buphachat C; Seksarn P
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):208-11. PubMed ID: 22322138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function.
    Sørensen JD; Secher NJ; Jespersen J
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):257-61. PubMed ID: 7732797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in protein C and protein S levels in normal pregnancy.
    Faught W; Garner P; Jones G; Ivey B
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):147-50. PubMed ID: 7847526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.